V. Novakivskyy, “PHARMACO-ECONOMICBENEFITS OF CORRECTION OF ANEMIA WITH CONTINUOUS ERYTHROPOIETIN RECEPTOR ACTIVATOR:HEMODIALYSIS VSHEMODIAFILTRATION”, Ukr. J. Nephrol. Dial., no. 1(53), pp. 26-31, Mar. 2017.